Dr Chris J Kapelios (Laiko General Hospital, Athens, GR) discusses sacubitril / valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long-term Registry: bridging between the PARADIGM HF trial, ESC Guidelines and the real world.
Questions:
Why did you conduct this analysis?
How did you collect and analyse the data?
What were your findings?
How should this study influence practice and research with Sacubitril/valsartan?
Interviewer: Liam O'Neill
Videographer: Mike Knight
Filmed on site at HFA 2019.